4-Amino-N-(2,6-dimethylpyrimidin-4-yl)benzenesulfonamide monosodium salt

Suppliers

Names

[ CAS No. ]:
2462-17-1

[ Name ]:
4-Amino-N-(2,6-dimethylpyrimidin-4-yl)benzenesulfonamide monosodium salt

[Synonym ]:
4-amino-N-(2,6-dimethylpyrimidin-4-yl)benzenesulfonamide,sodium

Chemical & Physical Properties

[ Boiling Point ]:
480.7ºC at 760mmHg

[ Melting Point ]:
295ºC dec.

[ Molecular Formula ]:
C12H14N4NaO2S

[ Molecular Weight ]:
301.32000

[ Flash Point ]:
244.5ºC

[ Exact Mass ]:
301.07400

[ PSA ]:
106.35000

[ LogP ]:
3.33850

[ Vapour Pressure ]:
2.12E-09mmHg at 25°C

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
WO9280000
CHEMICAL NAME :
Sulfanilamide, N(sup 1)-(2,6-dimethyl-4-pyrimidinyl)-, monosodium salt
CAS REGISTRY NUMBER :
2462-17-1
LAST UPDATED :
199203
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C12-H13-N4-O2-S.Na
MOLECULAR WEIGHT :
300.34
WISWESSER LINE NOTATION :
T6N CNJ B1 D1 FMSWR DZ &-NA-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2400 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 94,338,1953
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1250 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 9,286,1959
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 94,338,1953

Related Compounds

  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 3-[(2-Methoxy-phenyl)-methyl-amino]-propionic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • N-(3,5-dimethoxyphenyl)-2-({3-ethyl-4-oxo-6-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}sulfanyl)acetamide
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (E)-2-cyano-N-(3,5-dichlorophenyl)-3-[4-[(1-methylimidazol-2-yl)methoxy]phenyl]prop-2-enamide
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • ethyl 2-(2-(3-oxo-6-(p-tolylthio)-[1,2,4]triazolo[4,3-b]pyridazin-2(3H)-yl)acetamido)benzoate
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide